Holen Sie sich die Stockscreener-App
11.40
0.35%
0.04
Handel nachbörslich:
11.40
Schlusskurs vom Vortag:
$11.36
Offen:
$11.36
24-Stunden-Volumen:
74,016
Relative Volume:
0.68
Marktkapitalisierung:
$304.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-5.00%
1M Leistung:
+4.11%
6M Leistung:
-22.92%
1J Leistung:
+0.00%
1-Tages-Spanne:
$11.15
$11.66
1-Wochen-Bereich:
$11.15
$12.42
52-Wochen-Spanne:
$10.65
$17.19
Carlsmed Inc Stock (CARL) Company Profile
Firmenname
Carlsmed Inc
Sektor
Branche
Telefon
858-295-9290
Adresse
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
11.40 | 303.68M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
178.88 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
49.98 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
77.81 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Eingeleitet | BTIG Research | Buy |
| 2025-08-18 | Eingeleitet | BofA Securities | Buy |
| 2025-08-18 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Eingeleitet | Piper Sandler | Overweight |
| 2025-08-18 | Eingeleitet | Truist | Buy |
Carlsmed Inc Aktie (CARL) Neueste Nachrichten
Head to Head Review: Carlsmed (CARL) and The Competition - Defense World
Carlsmed Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks
Carlsmed (CARL) versus The Competition Head to Head Analysis - Defense World
Carlsmed (CARL) vs. Its Peers Financial Survey - Defense World
Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference - Defense World
Contrasting Carlsmed (CARL) & Its Peers - Defense World
Carlsmed (CARL) vs. Its Competitors Head-To-Head Contrast - Defense World
Carlsmed (CARL) versus The Competition Financial Contrast - Defense World
CARL: Personalized spine surgery platform posts 86% annual growth and expands into cervical market - TradingView
CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView
Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Target Price at $21.33 - Defense World
Carlsmed (CARL) versus Its Peers Financial Contrast - Defense World
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL) - The Globe and Mail
Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research - MarketBeat
Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives - simplywall.st
Head to Head Survey: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed Q4 Earnings Call Highlights - MarketBeat
Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook - Intellectia AI
Carlsmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill
Earnings call transcript: Carlsmed reports strong revenue, stock dips Q4 2025 - Investing.com
Carlsmed (NASDAQ:CARL) Issues Quarterly Earnings Results - MarketBeat
CARL: 2025 revenue surged 86% with expanding margins and strong adoption of new spine surgery products - TradingView
CARL: 2025 revenue surged 86% with expanding margins; 2026 guidance targets $70–$75M and robust growth - TradingView
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Carlsmed, Inc. Provides Revenue Guidance for the Year 2026 - marketscreener.com
Head to Head Comparison: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed announces clinical debuts of two spinal surgery solutions - Today's Medical Developments
Carlsmed Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
Carlsmed Unveils Custom Cervical Plating Tech - National Today
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference - Santé log
Carlsmed Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Head to Head Survey: Carlsmed (NASDAQ:CARL) & Check-Cap (NASDAQ:MBAI) - Defense World
Financial Contrast: Carlsmed (CARL) and Its Competitors - Defense World
Carlsmed Announces first corra™ personalized Cervical Plating Procedure - Orthopedics This Week
Carlsmed Announces first corra personalized Cervical Plating Procedure - Bitget
Analyzing Carlsmed (CARL) & Its Competitors - Defense World
CARL Should I Buy - Intellectia AI
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to “Hold” - Defense World
Financial Review: Carlsmed (CARL) versus Its Rivals - Defense World
Critical Comparison: Carlsmed (NASDAQ:CARL) vs. TransEnterix (OTCMKTS:TRXDW) - Defense World
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - The Manila Times
Carlsmed completes first surgery using aprevo bilateral posterior system By Investing.com - Investing.com Canada
Carlsmed completes first surgery using aprevo bilateral posterior system - Investing.com Nigeria
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - Orthopedics This Week
Both private equity firms who control a good portion of Carlsmed, Inc. (NASDAQ:CARL) along with institutions must be dismayed after last week's 11% decrease - simplywall.st
TD Waterhouse Canada Inc. Takes $2.03 Million Position in Carlsmed, Inc. $CARL - MarketBeat
Teacher Retirement System of Texas Purchases Shares of 175,000 Carlsmed, Inc. $CARL - MarketBeat
Finanzdaten der Carlsmed Inc-Aktie (CARL)
Es liegen keine Finanzdaten für Carlsmed Inc (CARL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Carlsmed Inc-Aktie (CARL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Option Exercise |
0.34 |
197,855 |
66,281 |
1,554,501 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Sale |
13.29 |
197,855 |
2,629,889 |
1,356,646 |
0.79%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):